Trevor J. Brown Chairman

In 1994, after 25 years in the Pharmaceutical Industry, which culminated as the Divisional Head of Medical Science Liaison at Upjohn, Trevor founded Premark Services, a strategic marketing consultancy. An MBA at City University Business School focused on pharmaceutical marketing and development strategy and his consultancy went on to specialise in providing innovative solutions for new product research, development and marketing. A specific focus on understanding the unmet medical needs of patients led to a series of epidemiology research projects which resulted in journal publications by expert physician collaborators. Researching to understand the priorities of those who fund healthcare led to programmes designed to improve patient management algorithms and outcomes and manage costs.

Trevor is currently the Chairman of Shermanbury Parish Council which represents the needs and wants of the residents of Shermanbury Parish; planning future housing developments and the maintenance of existing facilities. He is also a Trustee and Director of the League of the Helping Hand a national UK charity providing financial assistance to those in distress due to illness and circumstances beyond their control.

William C. Stewart, MD

Dr. Stewart is co-founder, CEO and Medical Director of PRN Pharmaceutical Research Network, LLC. With an extensive knowledge in ophthalmic clinical practice, clinical research, and pharmaceutical development Dr. Stewart’s company has a successful track record of supporting research initiatives, for both new and established companies, within the ophthalmology space.

Dr. Stewart is also co-founder of PRN PharmaFarm, LLC.

Dr. Stewart served on the Board of Directors of Encore vision, and was directly involved with the development of their novel presbyopia product, which was subsequently licensed to Novartis.

As a researcher, Dr. Stewart has been a principal investigator in numerous ophthalmic studies. He is the author of a medical text, Clinical Practice of Glaucoma (Slack, Inc, 1990), and is a contributing author to 11 ophthalmology texts and monographs. Dr. Stewart has published over 400 peer reviewed articles and letters primarily on the diagnosis and treatment of glaucoma in leading medical journals. He has given over 400 invited lectures at worldwide medical forums in 45 countries. He currently publishes in the area of ophthalmic start-up business and development.

Dr. Stewart received his B.A. in Chemistry from Southern Methodist University and his medical degree from Southwestern Medical School in Dallas, Texas. After finishing a residency in ophthalmology at the University of Missouri at Kansas City, he completed a glaucoma fellowship at Duke University Medical Center under renowned glaucoma thought leader, Dr. M. Bruce Shields.

Brian Hilberdink

Currently the President of LEO Pharma Inc. and Executive Vice President of North America for Leo Pharma A/S. He joined LEO in 2022 as part of a major transformation in the company’s 100+ year history. With the approval and launch of their first biologic, the ambition is to turn the US business into the primary global growth engine ahead of a planned IPO.

Prior to joining LEO, Brian spent over 25 years at Novo Nordisk A/S; a world-leading cardiometabolic company. Most recently, he was the SVP of Commercial and Sales in the United States and over-saw multiple blockbuster drugs in diabetes and obesity. He also previously held the role as the President of Novo Nordisk Canada Inc. and Corporate Vice President of Global Marketing leading the company’s future insulin portfolio; at the time, this represented the largest investment that had ever been made is in diabetes drug development.

Brian has become a regular speaker at various industry conferences on the evolution of the commercial model in the innovative pharmaceutical sector. He’s also served as an advisor and board member to several different organizations that are focused on sustainability in health care and public private partnerships.